1 not yet recruiting, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Germ Cell Cancer: new trials by email Literature Review of Germ Cell Cancer trials Research Report on Germ Cell Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1/2 Study Of PARP Inhibition With Olaparib To Enhance The Efficacy Of High-Dose Chemotherapy In Refractory And Relapsed Germ Cell Tumors Olaparib, Gemcitabine, Docetaxel - Germ Cell Cancer | Phase 1 / Phase 2 | Not yet recruiting | M.D. Anderson Cancer Center | 36 | 2027-03-01 | 2026-10-01 |
| B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) Fludarabine, Cyclophosphamide, MESNA - Pediatric Solid Tumor, Osteosarcoma | Phase 1 | Recruiting | St. Jude Children's Research Hospital | 48 | 2022-07-06 | 2026-05-19 |
Neoplasms, Germ Cell and Embryonal (2) · Adrenal Cortex Neoplasms (1) · Carcinoma (1) · Desmoplastic Small Round Cell Tumor (1) · Hepatoblastoma (1) · Melanoma (1) · Neuroblastoma (1) · Neurofibrosarcoma (1) · Osteosarcoma (1) · Rhabdoid Tumor (1) · Rhabdomyosarcoma (1) · Sarcoma (1) · Sarcoma, Clear Cell (1) · Sarcoma, Ewing (1) · Wilms Tumor (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Adrenal Cortex Diseases (1) · Adrenal Gland Diseases (1) · Adrenal Gland Neoplasms (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Fibrosarcoma (1) · Genetic Diseases, Inborn (1) · Kidney Diseases (1) · Kidney Neoplasms (1) · Male Urogenital Diseases (1)
Carboplatin (1) · Cyclophosphamide (1) · Docetaxel (1) · Etoposide (1) · Gemcitabine (1) · Mesna (1) · etoposide phosphate (1) · fludarabine (1) · fludarabine phosphate (1) · olaparib (1)
M.D. Anderson Cancer Center (1) · St. Jude Children's Research Hospital (1)
United States (2)
Chris DeRenzo, MD (1) · Yago Nieto, MD, PHD (1)